Abstract: Most women develop myomas during their lifetimes; however, 80% are asymptomatic. When symptoms are determined to be caused by myomas, a number of management options exist that include ''watchful waiting,'' medical therapy, surgery, or more recently uterine artery embolization and focused ultrasound. Myomectomy, either abdominal or laparoscopic, is an approach particularly suited for those women who wish future fertility. It seems clear that, in well trained and experienced hands, well-selected patients can have myomectomy performed under laparoscopic direction. Very large myomas are not as suitable for the laparoscopic approach, but are amenable to a uterine conserving procedure via laparotomy that is facilitated by a number of preoperative and intraoperative measures aimed to minimize or replace operative blood loss. These techniques should provide selected women a uterine conserving procedure with reduced morbidity.
Introduction
Seventy-seven percent of all women are reported to have myomas during their lifetimes; however, 80% are asymptomatic. Management options now include ''watchful waiting,'' medical therapy, uterine artery embolization, focused ultrasound, or surgery. Options for the surgical treatment of symptoms related to uterine myomas include endometrial ablation; abdominal, laparoscopic, and occasionally vaginal myomectomy; and abdominal, vaginal, and laparoscopic hysterectomy.
A recent study found that uterine myomas were the indication for surgery in 198,000 (33%) of the 598,000 hysterectomies performed in the United States during 1999. Only 30,000 myomectomies were performed during that year. However, concerns that hysterectomy is safer, is associated with less blood loss or that sarcoma may be present are not supported by recent reports.
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Indications for Myomectomy
Serious medical conditions, such as severe anemia or ureteral obstruction, may need to be addressed surgically. Surgery may also be indicated in women with myomas associated with heavy uterine bleeding, pelvic pain or pressure, urinary frequency, or incontinence that compromise quality of life. Abnormal uterine bleeding is the most common symptom reported by women with uterine myomas, although frequently such bleeding is not related to the myomas per se, particularly when the endometrial cavity is a normal size and when the myomas are intramural or subserosal. Submucous myomas seem to frequently cause abnormal uterine bleeding and, if possible they are best managed with hysteroscopic myomectomy provided the size, number, and myometrial location are suitable for such an approach. Pelvic pain from myoma degeneration is uncommon but is often successfully treated with analgesics and observation until symptoms resolve. Torsion of a pedunculated subserosal myoma may produce acute pain that often requires surgical intervention, either via laparotomy or laparoscopy. Back pain may rarely be related to the presence of myomas, however, other possible causes should be considered.
Neither intramural nor subserosal myomas seem to affect fertility rates and removal has not been shown to increase fertility. 3 However, the presence of submucous myomas seems to decrease fertility and removal seems to improve fertility outcomes. Therefore, proper evaluation of the uterine cavity is important for any woman considering myomectomy to improve fertility. Magnetic resonance imaging (MRI) is the best method to detect submucous myomas, but is expensive. 4 Hysteroscopy and saline infusion sonography are also excellent methods and provide more accurate information than either transvaginal sonography or hysterosalpingography.
Before myomectomy performed to enhance fertility, risks including operative and anesthetic risks, infection, postoperative adhesions, a small risk of uterine rupture, increased likelihood that cesarean section will be used for delivery, and the expense, discomfort, and time for recovery should be considered.
The incidence of sonographically detected myomas during pregnancy is low, approximately 1.5%, and only very rarely does the presence of a myoma lead to an unfavorable pregnancy outcome. One study of 167 women diagnosed with myomas among 12,600 sonographically screened pregnant women found no significant differences between women with and without myomas with regard to the incidence of preterm delivery, premature rupture of membranes, fetal growth restriction, placenta previa, placental abruption, postpartum hemorrhage, or retained placenta. Only cesarean section was more common among women with myomas (23% vs. 12% P<0.001).
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Another study of 15,104 pregnancies without myomas compared with 401 women with myomas found no increase in the risk of premature rupture of membranes, operative vaginal delivery, chorioamnionitis, or endomyometritis. However, there was some increased risk of preterm delivery (19.2% vs. 12.7%), placenta previa (3.5% vs. 1.8%), and postpartum hemorrhage (8.3% vs. 2.9%). Cesarean section was again significantly more common (49.1% vs. 21.4%). 6 No data are available comparing pregnancy outcomes after myomectomy with women with untreated myomas.
Abdominal Myomectomy
Hysterectomy has been considered a safer procedure than myomectomy, but 7 Operating times were greater in the myomectomy group (200 vs. 175 min), and estimated blood loss was greater in the hysterectomy group (484 vs. 227 mL). However, the risks of hemorrhage, febrile morbidity, unintended surgical procedure, life-threatening events, and rehospitalization did not differ. Five percent of the women in the myomectomy group sustained complications; 1 cystotomy, 2 reoperations for small bowel obstruction, and 6 women with ileus. Thirteen percent of women in the hysterectomy group had complications; 1 cystotomy, 1 ureteral injury, 3 bowel injuries, 6 pelvic abscesses, and 8 women with ileus. The authors concluded that myomectomy should be considered as a safe alternative to hysterectomy.
Myomectomy may be considered for women even with large uterine myomas who wish to retain their uterus. 8 Ninetyone women with uterine fibroids equal to or larger than 16 weeks size had abdominal myomectomy performed and mean operating time was 236 minutes (range 120 to 390 min) and mean estimated blood loss was 794 mL (range 50 to 3000 mL). Use of the cell saver eliminated the need for blood transfusion in all but 7 (8%) women. No woman had a uterine sarcoma or adenocarcinoma and none required conversion to hysterectomy. The results compare favorably to prior studies of hysterectomy for similar size uteri.
Laparoscopic Myomectomy
Currently available instruments make laparoscopic myomectomy feasible, although the wide application of this approach may be limited by the size and number of myomas reasonably removed, and the technical difficulty of laparoscopic suturing. However, studies suggest that when performed by experienced laparoscopic surgeons, laparoscopic myomectomy is safe and efficacious. A series of 368 women undergoing laparoscopic myomectomy with removal of 768 myomas reported a mean operating time of 100 minutes (range 30 to 300). 9 The significant complications were limited to one sigmoid injury that was repaired laparoscopically. In addition, 10 women (2.7%) received cell-saver autologous blood, and 4 required postoperative blood transfusion. Of 332 consecutive women undergoing laparoscopic myomectomy for symptomatic myomas smaller than 15 cm, 3 required conversion to laparotomy. 10 Another case series showed the feasibility of laparoscopic surgery in women with large myomas. Laparoscopic myomectomy was performed on 144 women for myomas ranging from 5 to 18 cm (mean, 7.8 cm), most of which were intramural or submucosal (n = 108). Operating time ranged from 58 to 180 minutes with an average of 95 minutes and only 2 (1.4%) women required conversion to laparotomy. 11 
Comparative Studies
High quality evidence seems to confirm the safety and reduced morbidity associated with laparoscopic myomectomy, at least in appropriately selected patients and when performed by experienced laparoscopic surgeons. A randomized clinical trial comparing abdominal and laparoscopic myomectomy showed that the laparoscopic procedure was associated with less postoperative pain, shorter hospital stay, and shorter recovery than with abdominal surgery. 12 In another clinical trial involving 40 women, with 1 to 4 subserous or intramural myomas between 3 and 6 cm were randomized to abdominal or laparoscopic myomectomy. Hysteroscopic evaluation excluded women with submucous myomas. The authors reported less postoperative pain (1.
than women having laparoscopic myomectomy. Three women in the abdominal myomectomy group, but none who had laparoscopic surgery, required blood transfusion. 13 
Patient Selection
The selection of patients appropriate for laparoscopic myomectomy should include consideration of avoiding excessive blood loss, prolonged operating time, or the need to convert to laparotomy. Appropriate selection criteria will depend on the skill and experience of the surgeon. The size and number of myomas may limit surgery, but also the positions of the myomas relative to vessels or fallopian tube and depth of penetration into myometrium may determine the need to opt for laparotomy. MRI is particularly helpful in determining the feasibility of laparoscopic surgery, because it has a high degree of accuracy in determining the sizes, positions, and number of uterine myomas 4 and is effective at distinguishing leiomyomas from nodular adenomyosis, pathology that may not be particularly suited to local excision. MRI is also the best imaging modality for evaluation of submucous myoma penetration into the myometrium.
14 Therefore, MRI can help define what can be expected at surgery, might help the surgeon avoid missing myomas during surgery, or may indicate that laparoscopic surgery is not feasible. MRI is not technique dependent and has low interobserver variability for submucous myomas, intramural myomas, and adenomyosis when compared with transvaginal sonography, saline-infusion sonography, and hysteroscopy.
Treating Preoperative Anemia
Erythropoetin a and epipoetin, recombinant forms of erythropoietin, are used to increase preoperative hemoglobin concentrations in cardiac, orthopedic, and neurologic surgery. In particular, a prospective, nonrandomized study of the use of epipoetin found significant increases in hemoglobin concentrations both before, and after, gynecologic surgery. 15 Gonadal releasing hormone agonists (GNRHa) may be used to stop abnormal uterine bleeding to facilitate restoration of hemoglobin and iron stores and to allow for more elective timing of surgery. Women with a low initial hemoglobin (mean, 10.2 g) were randomized preoperatively to GNRHa plus oral iron or placebo plus oral iron. After 3 months, 74% of the women treated with GNRHa and iron had a hemoglobin greater than 12 g compared with 46% of those treated with iron alone.
Abdominal Myomectomy Technique
Perhaps the main concern with abdominal myomectomy is the possibility of excessive blood loss. A randomized trial found that injection of vasopressin into myomas was as effective in limiting blood loss as mechanical occlusion of the uterine and ovarian vessels. Uterine
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Parker incisions made transversely and parallel to the arcuate vessels may reduce bleeding (Fig. 1) . Midline vertical uterine incisions cut across multiple arcuate vessels and may lead to greater blood loss. 8, 16 The uterine incisions should be taken down through the myometrium and entire pseudocapsule until the myoma is clearly seen, as this is a relatively avascular plane.
Limiting the number of uterine incisions has been suggested to reduce adhesions. However, this technique often leads to tunneling within the myometrium, making hemostasis difficult. Incisions made directly over myomas allow easy access, and prompt closure of each incision to immediately secure hemostasis. Multiple uterine incisions may be needed, but adhesion barriers will help limit adhesion formation. 17, 18 Cell savers have been used extensively in orthopedic, cardiac, and neurologic surgery and should be considered for use during myomectomy. The device suctions blood from the operative field, mixes it with heparinized saline, filters it, and stores the blood for reinfusion (Fig. 2) . Use of the cell-saver decreases the need for blood transfusion and avoids the risks of infection and transfusion reaction.
Surgical Technique for Laparoscopic Myomectomy
Port placement should be based on the position and size of the myomas to be FIGURE 1. Midline vertical uterine incisions cut across multiple arcuate vessels, whereas transverse incisions are parallel to the arcuate vessels.
FIGURE 2. The cell saver suctions blood from the operative field, mixes it with heparinized saline, filters it, and stores the blood for reinfusion to the patient. removed. Laparoscopic suturing may be more ergonomic if there are 2 ports on the patient's right side; a 12 mm port about 2 cm medial to the iliac crest for suture access, and another 5 mm port lateral to the inferior epigastric vessels at the level of the umbilicus. 19 The left upper quadrant approach may be used for uterine size close to or above the umbilicus.
A dilute vasopressin solution is injected into the myoma (20 U in 100 mL of normal saline) taking care to avoid injecting into a blood vessel. A transverse incision is made over the myoma, carried down through the pseudocapsule and into the myoma which is then grasped with a tenaculum for traction. The relatively avascular plane between the myometrium and myoma is dissected until the myoma is free. Bleeding may be controlled with a bipolar electrosurgical forceps. Delayed absorbable sutures are placed in 1, 2, or 3 layers, as needed. Due to questions about the integrity of wounds after laparoscopic myomectomy, wound closure should approximate that performed during abdominal myomectomy as closely as possible. Morcellation of the myoma with an electromechanical device is accomplished under direct vision and the pelvis and abdomen are irrigated and the fluid suctioned.
Adhesions After Myomectomy
Adhesion formation has been well documented after myomectomy. A Cochrane review found that the absorbable adhesion barrier caleed TC-7 (Interceed, Ethicon Women Health and Urology, Somerville, NJ) reduced the incidence of adhesion formation, both de novo and reformation, at laparoscopy and laparotomy, but there are insufficient data to support its use to improve pregnancy rates. 20 A nonabsorbable barrier (GoreTex Newark, DE) may be superior to TC-7 in preventing adhesion formation but its usefulness in reproductive surgery is limited by the need to fix it to the uterus and, frequently, for later removal. There was limited evidence of effectiveness of another absorbable adhesion barrier made from sodium hyaluronate and carboxymethylcellulose (Seprafilm, Genzyme, Inc, Cambridge, MA) in preventing adhesion formation.
Rupture of Myomectomy Scar During Pregnancy
Uterine rupture during pregnancy or delivery as a consequence of abdominal myomectomy seems to be extremely rare. A report of 98,872 deliveries over 30 years found 76 cases of uterine rupture in the third trimester, but only one of these women had a prior abdominal myomectomy, whereas 16 women had no prior uterine incisions. 21 Another study of 137,582 pregnancies found 133 cases of uterine rupture after the 28th week of pregnancy, of which only 3 followed abdominal myomectomies. 22 The number of women who had a previous myomectomy in these 2 studies is not known, so the incidence of rupture cannot be calculated. Eighty-three women during the same period (1958 to 1960) had elective cesarean section for previous myomectomy scars and none had uterine rupture during pregnancy. However, when those studies were published, abdominal myomectomy was infrequently performed. It may be that the number of women attempting pregnancy after abdominal myomectomy was small or the number of successful pregnancies was low. It is possible, though, that uterine rupture after abdominal myomectomy occurs very rarely.
To date, no studies compare wound strength after laparoscopic or abdominal repair of the uterus, especially as this pertains to the ability to tolerate 794 Parker pregnancy and labor. Uterine rupture has been reported in 11 women after laparoscopic myomectomy. [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] Given that laparoscopic myomectomy is not commonly performed, 33 this number of occurrences might suggest that laparoscopic repair may be associated with a greater risk of subsequent rupture than if the uterine repair is achieved abdominaly. It is also possible that adverse outcomes are being more completely reported because the procedure is still in development. One study found that gross inspection of myomectomy scars at the time of cesarean section revealed thinner scars under more tension in 5 women who had laparoscopic myomectomy than 10 women who had prior abdominal myomectomy. The authors suggest that this might result from tissue destruction with liberal use of electrosurgical desiccation during laparoscopic surgery, although this theory has not been tested. 34 
Recurrence
The rate of recurrence of myomas after abdominal myomectomy has been reported to be 11% when one myoma and 26% if multiple myomas are found at the initial surgery. The possibility of higher recurrence rates after laparoscopic myomectomy has been suggested because of the inability to palpate and remove small myomas during the procedure. One study randomized 81 women to either laparoscopic or abdominal myomectomy and followed them with transvaginal sonography every 6 months for at least 40 months. Myomas larger than 1 cm were detected in 27% of women after laparoscopic myomectomy compared with 23% in the abdominal myomectomy group. However, no woman in either group required reoperation or other intervention for myomas during the study period. 35 
Conclusions
Abdominal myomectomy is the standard approach to the conservative treatment of uterine myomas. However, appropriately selected patients may benefit from the short hospital stay and quick recovery that laparoscopic surgery provides. Careful patient selection can decrease the likelihood of the inappropriate use of laparoscopic myomectomy and avoid the need to convert to laparotomy. Further study is needed to clarify differences in wound healing, adhesion formation, pregnancy rates, and adverse pregnancy outcomes after laparoscopic or abdominal myomectomy.
